Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Fluoxetine and Bupropion to Treat Patients With Depression and Alcoholism
This study is ongoing, but not recruiting participants.
Study NCT00449007 Information provided by National Institute on Alcohol Abuse and Alcoholism (NIAAA)
First Received: March 15, 2007 Last Updated: September 26, 2008
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Depression
Alcoholism
Suicidal Behavior
Additional conditions recognized in this trial
Depressive Disorder
Depressive Disorder, Major
More general conditions related to this trial
Alcohol-Related Disorders
Behavioral Symptoms
Disorders of Environmental Origin
Mental Disorders
Mood Disorders
Substance-Related Disorders
Interventions listed in this trial
fluoxetine
bupropion
More general drug interventions related to this trial
Antidepressive Agents
Antidepressive Agents, Second-Generation
Central Nervous System Agents
Dopamine Agents
Dopamine Uptake Inhibitors
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Neurotransmitter Uptake Inhibitors
Pharmacologic Actions
Physiological Effects of Drugs
Psychotropic Drugs
Serotonin Agents
Serotonin Uptake Inhibitors
Therapeutic Uses
Sponsors listed in this trial
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Back to top of Main Content
